260 related articles for article (PubMed ID: 28536050)
1. A systematic reactor design approach for the synthesis of active pharmaceutical ingredients.
Emenike VN; Schenkendorf R; Krewer U
Eur J Pharm Biopharm; 2018 May; 126():75-88. PubMed ID: 28536050
[TBL] [Abstract][Full Text] [Related]
2. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
[TBL] [Abstract][Full Text] [Related]
3. Kilogram-scale prexasertib monolactate monohydrate synthesis under continuous-flow CGMP conditions.
Cole KP; Groh JM; Johnson MD; Burcham CL; Campbell BM; Diseroad WD; Heller MR; Howell JR; Kallman NJ; Koenig TM; May SA; Miller RD; Mitchell D; Myers DP; Myers SS; Phillips JL; Polster CS; White TD; Cashman J; Hurley D; Moylan R; Sheehan P; Spencer RD; Desmond K; Desmond P; Gowran O
Science; 2017 Jun; 356(6343):1144-1150. PubMed ID: 28619938
[TBL] [Abstract][Full Text] [Related]
4. Emerging Trends in Flow Chemistry and Applications to the Pharmaceutical Industry.
Bogdan AR; Dombrowski AW
J Med Chem; 2019 Jul; 62(14):6422-6468. PubMed ID: 30794752
[TBL] [Abstract][Full Text] [Related]
5. Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework.
Cervera-Padrell AE; Skovby T; Kiil S; Gani R; Gernaey KV
Eur J Pharm Biopharm; 2012 Oct; 82(2):437-56. PubMed ID: 22820647
[TBL] [Abstract][Full Text] [Related]
6. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
7. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
[TBL] [Abstract][Full Text] [Related]
8. Continuous flow technology vs. the batch-by-batch approach to produce pharmaceutical compounds.
Cole KP; Johnson MD
Expert Rev Clin Pharmacol; 2018 Jan; 11(1):5-13. PubMed ID: 29206489
[TBL] [Abstract][Full Text] [Related]
9. Early chemical development at Legacy Wyeth Research.
O'Brien MK; Kolb M; Connolly TJ; McWilliams JC; Sutherland K
Drug Discov Today; 2011 Jan; 16(1-2):81-8. PubMed ID: 21111844
[TBL] [Abstract][Full Text] [Related]
10. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
LaPorte TL; Wang C
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
[TBL] [Abstract][Full Text] [Related]
11. Continuous manufacturing and process analytical tools.
Maniruzzaman M; Douroumis D
Int J Pharm; 2015 Dec; 496(1):1-2. PubMed ID: 26647292
[No Abstract] [Full Text] [Related]
12. Process Analytical Technology for Crystallization of Active Pharmaceutical Ingredients.
Malwade CR; Qu H
Curr Pharm Des; 2018; 24(21):2456-2472. PubMed ID: 29956616
[TBL] [Abstract][Full Text] [Related]
13. Continuous Manufacturing in Pharmaceutical Process Development and Manufacturing.
Burcham CL; Florence AJ; Johnson MD
Annu Rev Chem Biomol Eng; 2018 Jun; 9():253-281. PubMed ID: 29879381
[TBL] [Abstract][Full Text] [Related]
14. Microreactors for continuous processing – How close to commercial utility?
Fortunak J; Confalone PN; Grosso JA
Curr Opin Drug Discov Devel; 2010; 13(6):642-4. PubMed ID: 21105486
[TBL] [Abstract][Full Text] [Related]
15. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Srai JS; Badman C; Krumme M; Futran M; Johnston C
J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
[TBL] [Abstract][Full Text] [Related]
16. Synthetic peptide API manufacturing: A mini review of current perspectives for peptide manufacturing.
Rasmussen JH
Bioorg Med Chem; 2018 Jun; 26(10):2914-2918. PubMed ID: 29735426
[No Abstract] [Full Text] [Related]
17. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
[TBL] [Abstract][Full Text] [Related]
18. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in continuous and semi-continuous processing of solid oral dosage forms: a review.
Teżyk M; Milanowski B; Ernst A; Lulek J
Drug Dev Ind Pharm; 2016 Aug; 42(8):1195-214. PubMed ID: 26592545
[TBL] [Abstract][Full Text] [Related]
20. Data completeness--the Achilles heel of drug-target networks.
Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
Nat Biotechnol; 2008 Sep; 26(9):983-4. PubMed ID: 18779805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
